Swedbank

Swedbank’s Medifast MED Stock Holding History

Swedbank’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,000	Closed	-$115K	–	711
2024 Q1	$115K	Hold	3,000	–	–	﹤0.01%	565
2023 Q4	$202K	Hold	3,000	–	–	﹤0.01%	691
2023 Q3	$225K	Hold	3,000	–	–	﹤0.01%	684
2023 Q2	$276K	Hold	3,000	–	–	﹤0.01%	683
2023 Q1	$311K	Hold	3,000	–	–	﹤0.01%	686
2022 Q4	$346K	Sell	3,000 -3,100	-51%	-$361K	﹤0.01%	681
2022 Q3	$661K	Hold	6,100	–	–	﹤0.01%	669
2022 Q2	$1.1M	Hold	6,100	–	–	﹤0.01%	636
2022 Q1	$1.04M	Hold	6,100	–	–	﹤0.01%	675
2021 Q4	$1.29M	Hold	6,100	–	–	﹤0.01%	674
2021 Q3	$1.18M	Buy	+6,100	New	+$1.5M	﹤0.01%	680

Other funds holding MED

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return